Amgen reportedly in talks to buy Horizon Therapeutics

Amgen Inc. is in advanced talks to buy drug company Horizon Therapeutics PLC, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year.

The U.S. biotechnology company AMGN was the last of three suitors standing in an auction for Horizon HZNP , the people said, after French drugmaker Sanofi SA FR:SAN SNY said Sunday it was out of the running. A... Amgen Inc. is in advanced talks to buy drug company Horizon Therapeutics PLC, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year.

The U.S. biotechnology company AMGN was the last of three suitors standing in an auction for Horizon HZNP , the people said, after French drugmaker Sanofi SA SAN SNY said Sunday it was out of the running.Horizon develops medicines to treat rare autoimmune and severe inflammatory diseases that are currently sold mostly in the U.S. Its biggest drug, Tepezza, is used to treat thyroid eye disease, an affliction characterized by progressive inflammation and damage to tissues around the eyes.

The company is Nasdaq-listed, but based in Ireland and has operations in Dublin, Deerfield, Ill., and a new facility in Rockville, Md.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

WSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon TherapeuticsAmgen is in advanced talks to buy drugmaker Horizon Therapeutics, people familiar with the matter say, in a deal likely to be valued at well over $20 billion Stock Options The people of the world hear our voice👊🏻 Iranian people are fighting against the dictator Support the people of Iran💚🤍❤️ IranRevolution Iran OJO: Amgen dispuesta a comprar Horizon por 20B. Es una adquisición de peso (una de las mayores de los últimos años).La adquisición le daría a Amgen acceso al pipeline de Horizon para enfermedades raras autoinmunes e inflamatorias, incluido su exitoso tratamiento Tepezza.
Source: WSJ - 🏆 98. / 63 Read more »

Amgen emerges frontrunner in Horizon deal as Sanofi drops bidAmgen Inc is in advanced talks to buy biotech company Horizon Therapeutics Plc , the Wall Street Journal reported on Sunday, while rival bidder French health group Sanofi announced it had dropped its bid.
Source: Reuters - 🏆 2. / 97 Read more »

Outside Voices: Preparing for inflection points in your business - Jacksonville Business JournalAs year changes, think of what changes might be on the horizon for your business.
Source: JaxBizJournal - 🏆 599. / 51 Read more »

Outside Voices: Preparing for inflection points in your business - Jacksonville Business JournalAs year changes, think of what changes might be on the horizon for your business.
Source: JaxBizJournal - 🏆 599. / 51 Read more »